On July 19, the Department of Health and Human Services (HHS) announced that Secretary Alex Azar requested FDA Commissioner Scott Gottlieb to establish a working group to examine how to safely import prescription drugs from other countries in the event of a dramatic price increase for a drug produced by one manufacturer and not protected by patents or exclusivities. See Trump Administration to Explore Drug Imports to Counter Price Hikes (Washington Post, 7/19/18).
HHS Working Group on Drug Importation (Washington Update July 25, 2018)
by familyvoices | Jul 25, 2018 | NCFPP, Policy Action, Washington Update